Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?

Circ Cardiovasc Interv. 2020 Apr;13(4):e009127. doi: 10.1161/CIRCINTERVENTIONS.120.009127. Epub 2020 Apr 16.

Authors

Davide Cao¹, Mauro Chiarito^{1

2}, Roxana Mehran¹

Affiliations

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York (D.C., M.C., R.M.).
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele - Milan, Italy (M.C.).

PMID: 32295418
DOI: 10.1161/CIRCINTERVENTIONS.120.009127

No abstract available

Keywords: C-reactive protein; Editorials; atherosclerosis; colchicine; inflammation; interleukins; percutaneous coronary intervention.

Publication types

Editorial
Comment

MeSH terms

Colchicine
Coronary Artery Disease* / diagnostic imaging
Coronary Artery Disease* / therapy
Humans
Inflammation
Percutaneous Coronary Intervention* / adverse effects

Substances

Colchicine